Clinical trialObsCompleted
Ghrelin Levels in Pancreatic Cancer Patients
Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer
- Outcome
- Finished, no results posted
- Phase
- Obs
- Status
- Completed
- Study type
- Observational
- Start
- April 2004
- Expected end
- September 2015
- Enrollment
- 72 participants
- Sites
- 1
- Primary outcomes
- To evaluate plasma ghrelin levels in patients with pancreatic cancer and compare with age matched controls
- Sponsor
- Other
- Results posted
- No
- Last update
- 14 October 2015
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The primary outcome measure for this study is plasma ghrelin level.
Detailed description public domain (ClinicalTrials.gov)
The primary outcome measure for this study is plasma ghrelin level, and the two primary comparison are: * Patients with cachexia versus patients without cachexia * Patients with cachexia versus healthy controls